Exciva GmbH
PrivateLast Round
Series B
Jan 20, 2026
Total Funding Raised
$72M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Exciva GmbH is a biopharmaceutical company that develops clinical-stage therapeutics for neuropsychiatric conditions, with a primary focus on agitation in patients with Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exciva GmbH Comparables
Compare Exciva GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| H. Lundbeck A/S | 79% | |
| IGC Pharma, Inc. | 78% | |
| Johnson & Johnson | 77% |
Exciva GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 20, 2026 | ||||
| Series A | Oct 26, 2021 |
Exciva GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series B |
| Dolby Family Ventures | Series B |
| Gimv | Series B |
| Andera Partners | Series B, Seed, Series A |
| Fountain Healthcare Partners | Series B |
| Landesbank Baden-Württemberg | Series B |
| Cure8 Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
$59M round completed.
- Jun 1, 2025
Monthly visitors grew 63% MoM, from 319 to 521.
Exciva GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Exciva GmbH's valuation, stock price, and market status.
Is Exciva GmbH a public or private company?
Exciva GmbH is a private company.
What is the current stock price of Exciva GmbH?
Exciva GmbH is a private company with no public stock price. No recent secondary market data is available.
How much is Exciva GmbH worth (valuation)?
Valuation information for Exciva GmbH is not publicly available.
Can I buy Exciva GmbH stock?
Exciva GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Exciva GmbH's last funding round?
Exciva GmbH's most recent funding round was Series B on January 20, 2026.
Who are the main investors in Exciva GmbH?
Key investors in Exciva GmbH include EQT Life Sciences, Gimv.
Will Exciva GmbH IPO soon?
No public IPO plans have been announced for Exciva GmbH.
How can I track Exciva GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Exciva GmbH's secondary market activity and sign up for updates.